We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Pfizer Healthcare Ireland

9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24,
Telephone: +353 1 467 6500
Fax: +353 1 467 6501
Medical Information Direct Line: 1 800 633 363
Medical Information Website: http://www.pfizermedicalinformation.ie
Patient Information Leaflet last updated on medicines.ie: 15/06/2017
PIL Cardura XL 4mg, 8mg

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 15/06/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Updated on 18/02/2016 and displayed until 15/06/2017
Reasons for adding or updating:
  • Change of contraindications
Updated on 22/10/2015 and displayed until 18/02/2016
Reasons for adding or updating:
  • Change to side-effects
  • Change to improve clarity and readability
  • Correction of spelling/typing errors
Updated on 05/06/2015 and displayed until 22/10/2015
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Correction of spelling/typing errors
Updated on 02/10/2014 and displayed until 05/06/2015
Reasons for adding or updating:
  • Change to date of revision
  • Change to name of manufacturer
Updated on 03/06/2013 and displayed until 02/10/2014
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 05/04/2013 and displayed until 03/06/2013
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 10/12/2009 and displayed until 05/04/2013
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 09/11/2009 and displayed until 10/12/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to side-effects
  • Change to drug interactions
  • Change to date of revision
Updated on 02/07/2008 and displayed until 09/11/2009
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 25/03/2008 and displayed until 02/07/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 04/09/2007 and displayed until 25/03/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 03/05/2007 and displayed until 04/09/2007
Reasons for adding or updating:
  • Change of inactive ingredient
Updated on 28/11/2005 and displayed until 03/05/2007
Reasons for adding or updating:
  • Change of manufacturer
Updated on 16/08/2005 and displayed until 28/11/2005
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 04/10/2004 and displayed until 16/08/2005
Reasons for adding or updating:
  • Change of manufacturer
Updated on 16/09/2004 and displayed until 04/10/2004
Reasons for adding or updating:
  • New PIL for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Doxazosin mesilate